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Abstract
Objective To assess the cost effectiveness of laparoscopic
hysterectomy compared with conventional hysterectomy
(abdominal or vaginal).
Design Cost effectiveness analysis based on two parallel trials:
laparoscopic (n = 324) compared with vaginal hysterectomy
(n = 163); and laparoscopic (n = 573) compared with abdominal
hysterectomy (n = 286).
Participants 1346 women requiring a hysterectomy for reasons
other than malignancy.
Main outcome measure One year costs estimated from NHS
perspective. Health outcomes expressed in terms of QALYs
based on women’s responses to the EQ-5D at baseline and at
three points during up to 52 weeks’ follow up.
Results Laparoscopic hysterectomy cost an average of £401
($708; €571) more (95% confidence interval £271 to £542) than
vaginal hysterectomy but produced little difference in mean
QALYs (0.0015, − 0.015 to 0.018). Mean differences in cost and
QALYs generated an incremental cost per QALY gained of
£267 333 ($471 789; €380 437). The probability that
laparoscopic hysterectomy is cost effective was below 50% for a
large range of values of willingness to pay for an additional
QALY. Laparoscopic hysterectomy cost an average of £186
($328; €265) more than abdominal hysterectomy, although 95%
confidence intervals crossed zero ( − £26 to £375); there was
little difference in mean QALYs (0.007, − 0.008 to 0.023),
resulting in an incremental cost per QALY gained of £26 571
($46 893; €37 813). If the NHS is willing to pay £30 000 for an
additional QALY, the probability that laparoscopic
hysterectomy is cost effective is 56%.
Conclusions Laparoscopic hysterectomy is not cost effective
relative to vaginal hysterectomy. Its cost effectiveness relative to
the abdominal procedure is finely balanced.
Introduction
Hysterectomy is a common operation, with up to 100 0001 and
550 0002 procedures undertaken annually in the United
Kingdom and the United States, respectively. Traditionally, most
hysterectomies have been undertaken through the abdomen, but
there have been no randomised comparisons of abdominal and
vaginal hysterectomy. The advent of laparoscopic approaches to
hysterectomy offers the prospect of improved outcomes and
gains in cost effectiveness through reduced severity of convales-
cence and shorter length of inpatient stay. With the exception of
some observational studies3–5 and small randomised trials,6 7
however, little is known about the costs and cost effectiveness of
laparoscopic forms of hysterectomy relative to conventional
(abdominal and vaginal) approaches.
The eVALuate trial is the largest trial of laparoscopic hyster-
ectomy compared with standard methods yet undertaken.8 This
report describes a cost effectiveness analysis undertaken with
eVALuate data.
Methods
Overview
Over one year we estimated costs from the NHS perspective and
expressed benefits in terms of quality adjusted life years
(QALYs).We undertook two separate comparisons: laparoscopic
hysterectomy (ALH) versus abdominal and laparoscopic hyster-
ectomy (VLH) versus vaginal hysterectomy.
Trial design
Full details of the design of the eVALuate trial are reported in
the accompanying paper.8 All the women we randomised had
gynaecological symptoms that indicated the need for a hysterec-
tomy. We excluded women with confirmed or suspected
malignant disease of the genital tract. Once a woman was
included, the surgeon decided which form of conventional
hysterectomy was most appropriate, abdominal or vaginal.
Women were then randomised between the selected conven-
tional procedure and laparoscopic procedure in two parallel
trials: vaginal versus laparoscopic hysterectomy and abdominal
versus laparoscopic hysterectomy. We used a 2:1 randomisation
schedule in favour of the laparoscopy.
Of the 1380 women who were randomised into the study, 34
withdrew before surgery was undertaken. Of the 859 women
who were allocated to and received treatment in the abdominal
part of the study, 573 were randomised to laparoscopic hysterec-
tomy and 286 to abdominal hysterectomy. Of the 487 who were
allocated to and received treatment in the vaginal part of the
trial, 324 patients were randomised to laparoscopic hysterectomy
and 163 to vaginal hysterectomy. We carried out the economic
analysis on data from the 1346 women who did not drop out
before surgery over a median follow up of 52 weeks (range 6-52;
mean 46.88).
Measurement of resource use
For purposes of costing we collected data on the use of resources
under several headings.
Theatre—Clinical staff completed case record forms on the
use of theatre resources. This included time in theatre and recov-
ery room; type of hysterectomy undertaken; use of prophylactic
antibiotics and anticoagulants; type of anaesthetic; method of
haemostasis; and use of specific consumables such as disposable
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trocars and scissors. Details of intraoperative complications were
also collected, including the need for blood transfusion. JA, who
was blinded to treatment allocation, estimated any additional use
of resources associated with these complications (such as drugs
or tests).
Main admission to hospital—Case record forms were also used
to measure use of other resources during a woman’s main
admission, including total length of stay in hospital (by type of
ward) and the use of urinary catheterisation. We also collected
details of postoperative complications during admission, includ-
ing any blood transfusion and whether a woman had to be
returned to theatre; additional resource use was estimated as for
operative complications.
Follow up—At the six week clinic follow up visit, we used case
record forms to collect data on the incidence of any
complications; any additional resource use was estimated as for
the immediate postoperative period. Patients also completed a
questionnaire at this point, which included questions on number
of inpatient days and outpatient, day case, and general practice
visits made for any reason after they left hospital. Patients were
also asked to complete similar questionnaires 4 and 12 months
after hospital discharge.
Unit costs
We used UK unit costs at 1999-2000 prices to value the use of
resources. Table 1 details the key unit costs, together with their
sources. We costed any inpatient days in hospital after the main
admission using average inpatient costs per day from English
hospitals.13
Health outcomes
The health outcomes of the alternative forms of hysterectomy
were assessed in terms of quality adjusted life years (QALYs).
This reflects any mortality and differences in health-related qual-
ity of life based on women’s responses to the EQ-5D
questionnaire at baseline and at up to three points after hospital
discharge (six weeks, four months, and one year). The EQ-5D is a
generic measure of health status, where health is characterised
on five dimensions (mobility, self care, ability to undertake usual
activities, pain, anxiety/depression).14 At each point of follow up,
women were asked to indicate their health on each dimension
using one of three levels: no problems, moderate problems, and
severe problems. Each response placed a woman into one of 245
mutually exclusive health states, and a value for each of these has
previously been estimated on the 0 (equivalent to dead) to 1
(equivalent to good health) “utility” scale based on interviews
with a sample of 3395 members of the UK public.15 Hence, each
woman in the trial had a health utility score at up to four time
points and, by using area under the curve methods16 which effec-
tively multiplies utility by time, we translated these observations
into QALYs over each woman’s period of follow up. In estimat-
ing mean QALYs in each group, we used regression methods to
adjust for differences in baseline EQ-5D utility.
Analysis
We used STATA (release 6.0, College Station TX) for statistical
analyses. As a result of staggered entry into the trial, 182 women
were not followed up for a full year.We therefore estimated mean
costs and QALYs over one year by using methods to adjust for
censored data.17 18 Given the short time horizon, costs and
QALYs remain undiscounted. To account for the skewed nature
of the data, we calculated 95% confidence intervals for differen-
tial costs and QALYs using the bias corrected and accelerated
bootstrap method.19 20 Cost effectiveness analysis was undertaken
to relate differential mean costs and QALYs associated with the
alternative arms of the trial, with incremental cost effectiveness
ratios (ICERs) calculated as appropriate. To account for
uncertainty due to sampling variation in cost effectiveness, we
plotted cost effectiveness acceptability curves,21 showing the
probability of laparoscopic hysterectomy being more cost effec-
tive than conventional hysterectomy for different maximum lev-
els that the decision maker may be willing to pay for an
additional QALY.
Results
Resource use
Table 2 provides a summary of the key measures of resource use
in the trial; results are presented separately for the two compari-
sons in the study. For the comparison of laparoscopic and vagi-
nal hysterectomy, the main differences related to time in theatre
(mean 98 v 65 minutes, respectively) and the use of disposable
equipment in many laparoscopic hysterectomies—for example, a
disposable linear stapler was used to achieve haemostasis in 36%
of ovarian pedicles and 19% of uterine pedicles, and disposable
scissors were used in 37% of laparoscopic hysterectomies (more
details are available elsewhere22). No marked differences
emerged between the procedures in length of stay or use of
resources after the initial admission.
The second comparison, between laparoscopic and abdomi-
nal hysterectomy, showed rather more differences in terms of use
of resources (table 2). Again, time in theatre was longer with
laparoscopic hysterectomy (mean 108 v 74 minutes). Also, a high
proportion of laparoscopic procedures used disposable equip-
ment. Compared with abdominal hysterectomy, however, laparo-
scopic hysterectomy had a lower mean length of hospital stay
(3.95 v 5.11 days). During follow up, there were no differences in
use of resources that would be expected to have a large effect on
differential cost.
Costs
Table 3 shows mean and median costs per patient. For the com-
parison of laparoscopic and vaginal hysterectomy, the only
marked difference related to theatre cost, which reflects
differences in theatre times and the use of disposable equipment
in a large proportion of laparoscopic procedures. None of the
Table 1 Key unit costs used to value resource use measured in the trial
(1999-2000 prices)
Item of resource Unit Unit cost (£) Source
Ward:
General ward Day 135.50 Mean of two specific
hospitals recruiting to
eVALuate
High dependency unit Day 393.66 Sculpher et al9
Intensive care unit Day 866.83 Sculpher et al9
Theatre:
Staff (variable) Minute 2.26 Booth10 Gough11
Staff (fixed) Fixed 1.36 Booth10 Gough11
Overheads Minute 1.83 Mean of two specific
hospitals recruiting to
eVALuate
Selected consumables used during laparoscopic assisted procedure:
Linear stapler item 257.72 Manufacturer
Laparoscopic scissors item 120.44 Manufacturer
Disposable trocars item 76.57 Manufacturer
Visits:
GP visits Visit 15.75 Netten et al12
Outpatient hospital
visits
Visit 62.00 CIPFA13
Day care visits Visit 62.00 Assumed the same as
outpatient visit
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other cost components showed marked differences between the
groups. Overall, laparoscopic hysterectomy cost a mean of £401
(95% confidence interval £271 to £542) more per patient.
The comparison of laparoscopic with abdominal hysterec-
tomy showed that costs for laparoscopy were closer to, but still
higher than for, conventional hysterectomy. Amean difference of
£335 in theatre costs again reflects longer theatre times and the
use of disposable equipment with laparoscopy. However, the
shorter length of admission with laparoscopic hysterectomy off-
set some of that additional cost, with a mean saving in hotel costs
of £144. Overall, laparoscopic hysterectomy cost a mean of £186
more per patient, with 95% confidence intervals crossing zero
( − £26 to £375).
Health outcomes
There were no deaths during follow up. In terms of both mean
and median EQ-5D values, and for both comparisons, women
showed improvements between baseline and six weeks and
between six weeks and four months; and little change between
four months and a year (table 4). The utilities were used to calcu-
late QALYs for each woman over a one year period (table 4).
These differences were small and 95% confidence intervals
crossed zero. Mean QALYs per patient were higher with laparo-
scopic hysterectomy, both compared with vaginal hysterectomy
(0.0015, − 0.015 to 0.018) and the abdominal procedure (0.007,
− 0.008 to 0.023).
Table 2 Key resource use measured in two parts of trial comparing different methods of hysterectomy. Figures are numbers (percentages) of patients unless
stated otherwise
Item of resource use
Vaginal trial Abdominal trial
Laparoscopy (n=324) Vaginal (n=163) Laparoscopy (n=573) Abdominal (n=286)
Main admission to hospital
Time in theatre (minutes)*:
Mean (SD) 98.14 (35.45) 65.03 (27.87) 108.07 (33.33) 74.08 (23.86)
Median (IQR) 95 (73-120) 58 (47-75) 105 (89-125) 70 (60-85)
Total length of stay in hospital (days)†:
Mean (SD) 4.28 (2.02) 4.32 (1.99) 3.95 (2.36) 5.11 (2.70)
Median (IQR) 4 (3-5) 4 (3-5) 4 (3-5) 5 (4-6)
Six week follow up
Outpatient visits:
0 173 (77) 83 (70) 329 (72) 143 (67)
1 42 (19) 34 (29) 104 (23) 62 (29)
>1 11 (5) 2 (2) 24 (5) 10 (5)
GP visits:
0 53 (24) 32 (37) 103 (23) 47 (22)
1-5 169 (75) 84 (71) 349 (77) 161 (75)
>5 4 (2) 2 (17) 5 (1) 7 (3)
Inpatient visits:
0 217 (96) 113 (96) 426 (93) 205 (95)
1 6 (3) 5 (4) 28 (6) 10 (5)
2 3 (1) — 3 (1) —
Four month follow up
Outpatient visits:
0 143 (75) 83 (81) 289 (75) 119 (70)
1 36 (19) 14 (14) 76 (20) 35 (21)
>1 13 (7) 5 (5) 20 (5) 15 (9)
GP visits:
0 71 (37) 59 (58) 116 (30) 52 (31)
1-5 115 (60) 60 (59) 255 (66) 113 (67)
>5 6 (0.03) 3 (0.03) 14 (0.03) 4 (0.02)
Inpatient visits:
0 189 (98) 100 (98) 381 (99) 162 (96)
1 3 (1) 2 (2) 3 (1) 7 (4)
>1 — — 1 (0.01) —
One year follow up
Outpatient visits:
0 177 (81) 87 (77) 313 (75) 143 (73)
1 26 (12) 18 (18) 60 (14) 28 (15)
>1 15 (7) 8 (8) 45 (11) 17 (4)
GP visits:
0 55 (25) 26 (23) 95 (23) 47 (25)
1-5 131 (60) 72 (64) 259 (62) 117 (62)
>5 32 (15) 15 (13) 64 (15) 24 (13)
Inpatient visits:
0 213 (98) 104 (92) 402 (96) 177 (94)
>0 5 (2) 9 (8) 16 (4) 11 (6)
IQR=interquartile range.
*Calculated as patient’s preparation time plus time from first incision to last suture.
†Calculated as discharge date minus admission date.
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Cost effectiveness
For the comparison of laparoscopic and vaginal hysterectomy,
mean costs were £401 higher and mean QALYs 0.0015 higher
with laparoscopy. In this circumstance, the issue is whether deci-
sion makers are willing to pay the implied ICER—that is, the
mean difference in cost divided by the mean difference in
QALYs—here £267 333 (£401/0.0015). However, we estimated
mean differences in costs and QALYs with sampling uncertainty,
which is represented in the figure in the form of cost
effectiveness acceptability curves. This shows the probability that
laparoscopic hysterectomy is more cost effective than vaginal
hysterectomy for a range of maximum values that decision mak-
ers may place on an additional QALY. The probability that
laparoscopic hysterectomy is the more cost effective is never
above 50%.
For the comparison of laparoscopic hysterectomy and
abdominal hysterectomy, tables 3 and 4 show that laparoscopy
had higher mean costs (£186) and higher mean QALYs (0.007)
per patient. This generates an ICER of £26 571. The figure
shows the cost effectiveness acceptability curve for this compari-
son, reflecting the imprecision with which these mean
differences are estimated. This indicates that the higher the value
decision makers place on an additional QALY, the higher the
probability that laparoscopic hysterectomy will be more cost
effective than abdominal hysterectomy. For example, at a
maximum value of £30 000 the probability reaches 56%.
Sensitivity analysis
We conducted a sensitivity analysis to assess how differential
costs would have changed if all laparoscopic procedures had
been undertaken with reusable equipment (reusable scissors,
sutures rather than staples, and reusable trocars). We assumed
that there would be no impact on health outcomes from this
change in policy. The mean difference in cost between
laparoscopic and vaginal hysterectomy was reduced to £260 and
the incremental cost effectiveness ratio for laparoscopy fell to
£173 334. For the comparison with abdominal hysterectomy, the
equivalent figures were £74 and £10 571. If most of the surgical
equipment was disposable the incremental cost effectiveness
ratios were £1 320 667 for laparoscopic versus vaginal hysterec-
tomy and £259 428 for laparoscopic versus abdominal hysterec-
tomy. Details of further sensitivity analysis are available
elsewhere.22
Table 3 Comparison of costs between laparoscopic and standard hysterectomy (1999-2000 prices)
Vaginal trial Abdominal trial
Laparoscopy (n=324) Vaginal (n=163) Laparoscopy (n=573) Abdominal (n=286)
Mean Median (IQR) Mean Median (IQR) Mean Median (IQR) Mean Median (IQR)
Theatre cost 807 635 (513-919) 396 362 (309-420) 788 646 (523-890) 453 431 (381-489)
Hospital “hotel” cost 589 542 (407-678) 591 542 (407-678) 548 542 (407-678) 692 678 (542-813)
Other postoperative cost 14 0 (0-0) 18 0 (0-0) 21 0 (0-0) 13 0 (0-0)
Follow up cost at six weeks 144 46 (0-108) 89 46 (0-108) 193 46 (0-108) 128 46 (0-108)
Follow up cost at four
months
37 0 (0-46) 47 0 (0-46) 39 0 (0-46) 88 0 (0-46)
Follow up cost at one year 64 46 (0-46) 112 46 (0-46) 115 46 (0-46) 146 46 (0-46)
Total cost 1654 1253 1706 1520
Differential mean cost* (95%
CI)†
401 (271 to 542) 186 (−26 to 375)
IQR=interquartile range.
*Laparoscopic minus standard.
†95% non-parametric confidence interval based on 1000 bootstrap replications.
Table 4 Health outcomes measured in trial comparing different methods of hysterectomy: responses to EQ-5D and quality adjusted life years (QALYs)
Vaginal trial Abdominal trial
Laparoscopy (n=324) Vaginal (n=163) Laparoscopy (n=573) Abdominal (n=286)
Mean Median (IQR) Mean Median (IQR) Mean Median (IQR) Mean Median (IQR)
EQ-5D utilities
Baseline 0.746 0.760 (0.725-1) 0.758 0.796 (0.691-1) 0.716 0.760 (0.691-0.848) 0.690 0.725 (0.689-0.812)
Six weeks 0.875 0.907 (0.812-1) 0.852 0.863 (0.76-1) 0.832 0.869 (0.76-1) 0.833 0.883 (0.76-1)
Four months 0.911 0.971 (0.848-1) 0.918 0.959 (0.848-1) 0.886 0.959 (0.812-1) 0.866 0.888 (0.796-1)
One year 0.920 1 (0.881-1) 0.917 1 (0.861-1) 0.897 0.929 (0.848-1) 0.892 0.959 (0.822-1)
QALYs over one year* 0.899 0.897 0.870 0.862
Differential QALYs over
one year† (95% CI)‡
0.0015 (−0.015 to 0.018) 0.007 (−0.008 to 0.023)
*Adjusting for baseline EQ-5D utility.
†Laparoscopic minus standard.
‡95% non-parametric confidence interval based on 1000 bootstrap replications.
Decision maker's willingness to pay for an additional QALY (£000s)
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Discussion
We have shown that the mean cost of laparoscopic hysterectomy
is higher than that of standard hysterectomy, mainly due to the
additional cost of disposable instruments used in the procedure.
Differences in QALYs between laparoscopic and standard
hysterectomy over one year were small. If we focus on mean dif-
ferences in costs and QALYs, compared with vaginal
hysterectomy laparoscopy is unlikely to be considered cost effec-
tive as the additional cost associated with generating extra
benefit is much higher than the NHS has been willing to pay in
other contexts.23
The cost effectiveness compared with abdominal hysterec-
tomy is more finely balanced, mainly because of the shorter
mean inpatient stay associated with laparoscopy, which results in
lower additional costs. The incremental cost of laparoscopy per
additional QALY of £26 571 is towards the top of the range that
the National Institute for Clinical Excellence has shown itself
willing to accept for healthcare interventions in the NHS.23 Fur-
thermore, the mean differences in cost and QALYs are
measured imprecisely. Reflecting this, the probability of laparos-
copy being more cost effective than abdominal hysterectomy is
56% if the NHS is willing to pay up to £30 000 for an additional
QALY, indicating that the decision about value for money is
finely balanced. If surgeons use largely reusable equipment in
preference to relatively expensive disposables, the additional cost
of laparoscopic compared with abdominal hysterectomy would
fall to £74 and the incremental cost effectiveness ratio to
£10 571. Although this is more likely to be considered good
value for money, this sensitivity analysis should be interpreted
with caution as it assumes that the greater use of reusable equip-
ment would not affect outcomes.
Limitations
A limitation of our study is that health outcomes were not
measured until six weeks after the women were discharged from
hospital. This may have missed some of the health gains associ-
ated with any reduction in the severity of convalescence
associated with the laparoscopic procedure. However, differ-
ences in utility over a six week period would have a limited effect
on QALYs. The absence of utility data during that period is
unlikely to change the probable conclusion that laparoscopic
rather than vaginal hysterectomy is not cost effective. Given that
the cost effectiveness in the comparison with abdominal hyster-
ectomy is more finely balanced, more accurate assessment of the
effect of convalescence on utility may be more important in this
group.
We used a health service perspective to estimate the costs of
the alternative procedures. Any differential impact of the proce-
dures on time away from usual activities, including paid employ-
ment, might be reflected in differential productivity costs. The
issue of whether productivity costs should be included in cost
effectiveness analysis and, if so, how, is a source of controversy.24
The eVALuate trial collected data on time away from paid work.
These showed that the mean (SD) number of days it took women
to return to work after laparoscopic hysterectomy (78.68, SD
44.2) was similar to that in patients undergoing the vaginal pro-
cedure (70.21, SD 34.4), and this would not have altered the rela-
tive cost effectiveness of these two procedures. However, in the
other comparison, women who underwent laparoscopic
hysterectomy took fewer days off work than women who under-
went the abdominal procedure (77.8 (39.5) v 94.87 (60.0)). If all
or part of this difference can reasonably be reflected in terms of
productivity savings in monetary terms, this would strengthen
the case for laparoscopic hysterectomy to be considered more
cost effective than abdominal hysterectomy.
In conclusion, laparoscopic hysterectomy is unlikely to be
considered cost effective relative to vaginal hysterectomy. Its cost
effectiveness relative to the abdominal procedure is finely
balanced.
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